Scribe records upsized $129M IPO to bankroll lipid-lowering genetic meds
Fierce Biotech
|
July 24, 2026
X min read
Fierce Biotech
|
July 24, 2026
Share on Social
More like this
Media
Can Geneticists Fight Disease by Targeting ‘Nurture’ Instead of ‘Nature’?
September 8, 2026
The New York Times
Read Now
Press
Can Geneticists Fight Disease by Targeting ‘Nurture’ Instead of ‘Nature’?
September 8, 2026
The New York Times
Read Now
